Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors

Clinical Cancer Research

Volumn 2, Issue 8, 1996, Pages 1353-1359

  Allay, James A ^a,b   Koç, Omer N ^a   Davis, Brian M ^a   Gerson, Stanton L ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c BRB 3W ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NITROSOUREA DERIVATIVE; TRANSFERASE; TUMOR MARKER;

ARTICLE; BONE MARROW SUPPRESSION; BURST FORMING UNIT; CANCER SURVIVAL; COLONY FORMING UNIT; COVALENT BOND; DNA ADDUCT; DNA REPAIR; GENE EXPRESSION; GENETIC TRANSFECTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETROVIRUS; STEM CELL;

ANTIGENS, CD34; CARMUSTINE; DNA, COMPLEMENTARY; DRUG RESISTANCE, NEOPLASM; GENE TRANSFER TECHNIQUES; HEMATOPOIETIC STEM CELLS; HUMANS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RETROVIRIDAE;

EID: 0029782310     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Schreml, W., Lohrmann, H., and Anger, B. Stem cell defects after cytoreductive therapy in man. Exp. Hematol., 13. 31-42, 1985.
2. Levin, V. Chemotherapy of primary brain tumors. Neuro Clin., 3: 855-866, 1985.
3. Boice, J. J , Greene, M. H., and Killen, J. Y., Jr. Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methylCCNU) N. Engl. J. Med., 309: 1079-1084, 1983.
4. Galski, H., Sullivan, M., Willingham, M., Chin, K., Gottesman, M., Pastan, I., and Merlino, G. Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin-induced leukopenia. Mol. Cell. Biol., 9: 4357-4363, 1989.
5. Hanania, E G., and Deisseroth, A. B. Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Therapy, 1: 21-25, 1994.
6. McLachlin, J. R., Eglitis, M. A., Ueda, K., Kantoff, P. W., Pastan, I. H., Anderson, W. F., and Gottesman, M. M. Expression of a human complementary DNA for the multidrug resistance gene in murine hematopoietic precursor cells with the use of rettoviral gene transfer. J. Natl. Cancer Inst., 82: 1260-1263, 1990.
7. Mickisch, G., Merlino, G., Galski, H., Gottesman, M., and Pastan, I. Trasgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Proc. Natl. Acad. Sci. USA, 88: 547-551, 1991.
8. Mickisch, G., Aksentijevich, I., Schoenlein, P., Goldstein, L., Galski, H., Stahle, C., Sachs, D., Pastan, I., and Gottesman, M. Transplantation of bone marrow cells from transgenic mice expressing the human MDR1 gene results in long-term protection against the myelosuppressive effect of chemotherapy in mice. Blood, 79: 1087-1093, 1992.
9. Podda, S., Ward, M., Himelstein, A., Richardson, C., de la Flor-Weiss, E., Smith, L., Gottesman, M., Pastan, I., and Bank, A. Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Natl. Acad. Sci. USA., 89: 9676, 1992.
10. Sorrentino, B., Brandt, S., Bodine, D., Gottesman, M., Pastan, I., Cline, A., and Nienhuis, A. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science (Washington DC), 257: 99-103, 1992.
11. May, C., Gunther, R., and McIvor, R. Protection of mice from lethal doses of methotrexate by transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase activity. Blood, 86: 2439-2448, 1995.
12. Williams, D., Hsieh, K., DeSilva, A., and Mulligan, R. Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. J. Exp. Med., 166: 210-218, 1987.
13. Corey, C., DeSilva, A., Holland, C., and Williams, D. Serial transplantation of methotrexate-resistant bone marrow: protection of murine recipients from drug toxicity by progeny of transduced stem cells. Blood, 75: 337-343, 1990.
14. 34 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance. Gene (Amst.), 139: 269-274, 1994.
15. Ward, M., Richardson, C., Pioli, P., Smith, L., Podda, S., Goff, S., Hesdorffer, C , and Bank, A. Transfer and expression of the human multiple drug resistance gene in human CD34+ cells. Blood, 84: 1408-1412, 1994.
16. Flasshove, M., Banerjee, D., Mineishi, S., Li. M., Bertino, J., and Moore, M. Ex vivo expansion and selection of human CD34+ peripheral Wood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood, 85: 566-574, 1995.
17. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50: 6119-6129, 1990.
18. 1-bis(2-chloroethyl)-N-nitrosourea. Cancer Res., 42: 3102-3105, 1982
19. 6-methylguanine-DNA transmethylase from rat liver. J. Biol. Chem., 258: 2327-2333, 1983.
20. 6-alkylguanine-DNA alkyltransferase. Cancer Res., 44: 3806-3811, 1984.
21. 6-methylguanine lesions in methylated DNA. Nucleic Acids Res., 9: 3089-3103, 1981.
22. Allay, J , Dumenco, L., Koc, O., Liu, L., and Gerson, S. Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood, 85: 3342-3351, 1995.
23. Moritz, T., Mackay, W., Glassner, B., Williams, D , and Samson, L. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res., 55: 2608-2614, 1995
24. Maze, R., Camey, J. P., Kelley, M. R., Glassner, B J., Williams, D. A., and Samson, L. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent. Proc. Natl. Acad. Sci. USA, 93: 206-210, 1996.
25. Bodine, D. M., McDonagh, K. T., Brandt, S. J., Ney, P. A., Agricola, B., Byrne, E., and Nienhuis, A. W. Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc. Natl. Acad. Sci. USA, 87: 3738-3742, 1990.
26. 6 alkylguanine-DNA alkyltransferase activity in human myeloid cells. J. Clin. Invest., 76: 2106-2114, 1985.
27. 6-metnylguanine-DNA methyltransferase expression in human rhabdomyosarcoma cell lines and xenografts. Oncology Res., 4: 167-174, 1992.
28. Moritz, T., Patel, V., and Williams, D. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J. Clin. Invest , 93: 1451-1457, 1994.
29. Nolta, J., Yu, X., Bahner, I., and Kohn, D. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow. J. Clin. Invest., 90: 342-348, 1992.
30. Allay, J. A., Koc, O. N., Davis, B. M , and Gerson, S. L. Induction of nitrosourea resistance in human hemalopoietic progenitors by MGMT retroviral transduction Blood, 86 (Suppl. 10): 465a, 1995.
31. Miller, D., Adam, M., and Miller, A. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol., 10: 4239-4242, 1990.
32. Springett, G., Moen, R., Anderson, S., Blaese, R., and Anderson, W. Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J. Virol., 63: 3865-3869, 1989.
33. 6-benzylguanine plus BCNU. Blood, in press, 1996.
34. 6-alkyltransferase-DNA alkyltransferase. Cancer Res., 48: 1521-1527, 1988.
35. 6-alkylguanine during DNA synthesis in murine bone marrow hematopoietic precursors. Cancer Res., 47: 89-95, 1989.
36. Allay, J. A., Davis, B. M., and Gerson, S. L. MGMT expression in murine hematopoietic progenitors can serve as a dominant selectable marker Blood, 86 (Suppl. 1): 113a, 1995.
37. Zitvogel, L., Tahara, H., Cai, Q., Storkus, W., Muller, G., Wolf, S , Gately, M., Robbins, P., and Lotze, M. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum. Gene Ther., 5: 1493-1506, 1994.
38. Morgan, R., Couture, L., Elroy-Stein, O., Ragheb, J., Moss, B., and Anderson, W. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res., 20: 1293-1299, 1992.
39. Ghattas, J., Sanes, J., and Majors, J. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell. Biol., 11: 5848-5859, 1991.
40. Aran, J., Gottesman, M., and Pastan, I. Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector. Proc. Natl. Acad. Sci. USA, 91: 3176-3180, 1994.
41. Sugimoto, Y., Hrycyna, C., Aksentijevich, I., Pastan, I., and Gottesman, M. Coexpression of a multidrug-resistance gene (MDR1) and herpes simplex virus thymidine kinase gene as part of a bicistronic messenger RNA in a retrovirus vector allows selective killing of MDR1-transduced cells 1. Clin. Cancer Res., 1: 447-457, 1995.
42. Sugimoto, Y., Aksentijevich, I , Murray, G., Brady, R., Pastan, I , and Gottesman, M. Retroviral coexpression of a multidrug resistance gene (MDR1) and human α-galactosidase A for gene therapy of Fabry disease. Hum. Gene Ther., 6: 905-915, 1995.
43. 6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human. rat and mouse tissues. Carcinogenesis (Lond.), 7: 745-749, 1986.
44. Chaudhary, P., and Roninson, I. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66. 85-94, 1991.
45. Drach, D., Zhao, S., Drach, J., Mahadevia, R., Gattringer, C., Huber, H., and Andreeff, M. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood, 80: 2729-2734, 1992.
46. 6benzylguanine and BCNU in human colon cancer xenografts completely resistant to BCNU alone. Biochem. Pharmacol., 46: 483-491, 1993.
47. 6-benzylguanine and its effect on the sensitivity of a human glioma tumor to 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea. Cancer Commun., 2: 371-377, 1990.
48. 6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU). Biochem. Pharmacol., 46: 285-290, 1993.
49. 6-methylguamne. Carcinogenesis (Lond.), 12: 2305-2309, 1991.
50. 6-benzylguanine. Biochem. J., 298: 231-235, 1994.
51. 6-benzylguanine. Cancer Res., 53: 4750-4753, 1993.
52. 6-benzylguanine. Cancer Res., 54: 6221-6227, 1994.
53. Harris, L., Marathi, U., Edwards, C., Houghton, P., Srivastava, D., Vanin, E., Sorrentino, B., and Brent, T. Retroviral transfer of a bacterial alkyltransferase gene into murine bone marrow protects against chloroethylnitrosourea cytoxicity. Clin. Cancer Res., 1: 1359-1368, 1995.